0 NASDAQ Companies - June 11, 2019CymaBay Therapeutics Reports Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic SteatohepatitisRead More
0 NASDAQ Companies - June 11, 2019G1 Therapeutics to Present at Raymond James Life Sciences and MedTech ConferenceRead More
0 NASDAQ Companies - June 11, 2019Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with CannabidiolRead More
0 NASDAQ Companies - June 11, 2019Jiayin Group Reports First Quarter 2019 Unaudited Financial ResultsRead More
0 NASDAQ Companies - June 11, 2019LHC Group is top performer in latest CMS Star quality and patient satisfaction scoresRead More
0 TSX Venture News - June 11, 2019Medcolcanna Strengthens Board of Directors with Addition of Pharmaceutical ExecutiveRead More
0 NASDAQ Companies - June 11, 2019Mesoblast and JCR Pharmaceuticals Expand Japan License Agreement to Use of Mesenchymal Stem Cells in Newborns With Insufficient Blood Flow to the BrainRead More
